Latest & greatest articles for palliative care

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on palliative care or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on palliative care and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for palliative care

221. Fentanyl transdermal patches in palliative care: clinical effectiveness, safety, and guidelines

Fentanyl transdermal patches in palliative care: clinical effectiveness, safety, and guidelines Fentanyl transdermal patches in palliative care: clinical effectiveness, safety, and guidelines Fentanyl transdermal patches in palliative care: clinical effectiveness, safety, and guidelines CADTH Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database (...) . Citation CADTH. Fentanyl transdermal patches in palliative care: clinical effectiveness, safety, and guidelines. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). Rapid Response - Summary of Abstracts. 2014 Authors' conclusions Two evidence-based guidelines regarding the use of fentanyl transdermal patches for pain relief in palliative care patients were identified. Final publication URL Indexing Status Subject indexing assigned by CRD MeSH Administration, Cutaneous; Fentanyls

2014 Health Technology Assessment (HTA) Database.

222. Impact of community based, specialist palliative care teams on hospitalisations and emergency department visits late in life and hospital deaths: a pooled analysis. Full Text available with Trip Pro

Impact of community based, specialist palliative care teams on hospitalisations and emergency department visits late in life and hospital deaths: a pooled analysis. To determine the pooled effect of exposure to one of 11 specialist palliative care teams providing services in patients' homes.Pooled analysis of a retrospective cohort study.Ontario, Canada.3109 patients who received care from specialist palliative care teams in 2009-11 (exposed) matched by propensity score to 3109 patients who (...) received usual care (unexposed).The palliative care teams studied served different geographies and varied in team composition and size but had the same core team members and role: a core group of palliative care physicians, nurses, and family physicians who provide integrated palliative care to patients in their homes. The teams' role was to manage symptoms, provide education and care, coordinate services, and be available without interruption regardless of time or day.Patients (a) being in hospital

2014 BMJ

223. Fentanyl Transdermal Patches in Palliative Care: Clinical Effectiveness, Safety, and Guidelines

;25(5):578-96. Non-Randomized Studies No Comparator 6. Ljuca D, Husic S. Treatment of severe cancer pain by transdermal fentanyl. Bosn J Basic Med Sci. 2010 May;10(2):158-64. References from the American Journal of Hospice and Palliative Care 7. Takakuwa O, Oguri T, Maeno K, Yokoyama M, Hijikata H, Uemura T, et al. Analgesic effect of switching from oral opioids to a once-a-day fentanyl citrate transdermal patch in patients with lung cancer. Am J Hosp Palliat Care. 2013 Nov;30(7):726-9. 8. Chiou (...) Fentanyl Transdermal Patches in Palliative Care: Clinical Effectiveness, Safety, and Guidelines TITLE: Fentanyl Transdermal Patches in Palliative Care: Clinical Effectiveness, Safety, and Guidelines DATE: 29 May 2014 RESEARCH QUESTIONS 1. What is the clinical effectiveness and safety of fentanyl transdermal patches for pain relief in palliative care patients? 2. What are the evidence-based guidelines for the use of fentanyl transdermal patches for pain relief in palliative care patients? KEY

2014 Canadian Agency for Drugs and Technologies in Health - Rapid Review

224. Medically assisted nutrition for adult palliative care patients. Full Text available with Trip Pro

Medically assisted nutrition for adult palliative care patients. Many palliative care patients have a reduced oral intake during their illness. The management of this can include the provision of medically assisted nutrition with the aim of prolonging the length of life of a patient, improving their quality of life, or both. This is an updated version of the original Cochrane review published in Issue 4, 2008.To determine the effect of medically assisted nutrition on the quality and length (...) of life of palliative care patients.We identified studies from searching Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, CINAHL, CANCERLIT, Caresearch, Dissertation abstracts, SCIENCE CITATION INDEX and the reference lists of all eligible trials, key textbooks and previous systematic reviews. The date of the latest search was 26 March 2014.All relevant randomised controlled trials (RCTs) or prospective controlled trials (if no RCTs were found).We found no RCTs

2014 Cochrane

225. Benefits and costs of home palliative care compared with usual care for patients with advanced illness and their family caregivers. (Abstract)

Benefits and costs of home palliative care compared with usual care for patients with advanced illness and their family caregivers. Are home palliative care services associated with benefits to patients with advanced illness and family caregivers, and are they cost-effective?Compared with usual care, home palliative care is associated with increased odds of dying at home and fewer symptoms for patients with advanced illness. It is not associated with changes in caregiver grief. Cost

2014 JAMA

226. Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. (Abstract)

Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Patients with advanced cancer have reduced quality of life, which tends to worsen towards the end of life. We assessed the effect of early palliative care in patients with advanced cancer on several aspects of quality of life.The study took place at the Princess Margaret Cancer Centre (Toronto, ON, Canada), between Dec 1, 2006, and Feb 28, 2011. 24 medical oncology clinics were cluster randomised (...) (in a 1:1 ratio, using a computer-generated sequence, stratified by clinic size and tumour site [four lung, eight gastrointestinal, four genitourinary, six breast, two gynaecological]), to consultation and follow-up (at least monthly) by a palliative care team or to standard cancer care. Complete masking of interventions was not possible; however, patients provided written informed consent to participate in their own study group, without being informed of the existence of another group. Eligible

2014 Lancet Controlled trial quality: predicted high

227. Naloxone for Use in Long-term Care and Palliative Care: Clinical Effectiveness, Safety, and Guidelines

Naloxone for Use in Long-term Care and Palliative Care: Clinical Effectiveness, Safety, and Guidelines TITLE: Naloxone for Use in Long-term Care and Palliative Care: Clinical Effectiveness, Safety, and Guidelines DATE: 16 December 2013 RESEARCH QUESTIONS 1. What is the evidence for the clinical effectiveness and safety of naloxone to reverse the effects of narcotics in long-term care and palliative care patients? 2. What are the evidence-based guidelines for the use of naloxone to reverse (...) the effects of narcotics in long-term care and palliative care patients? KEY MESSAGE One evidence-based guideline was identified for the use of naloxone to reverse the effects of narcotics in long-term care and palliative care patients. No evidence was identified regarding the clinical effectiveness and safety of naloxone to reverse the effects of narcotics in long-term care and palliative care patients. METHODS A limited literature search was conducted on key resources including PubMed, The Cochrane

2014 Canadian Agency for Drugs and Technologies in Health - Rapid Review

228. Analgesia: use of patient/proxy patient controlled analgesia in palliative care

Analgesia: use of patient/proxy patient controlled analgesia in palliative care Analgesia: use of patient/proxy patient controlled analgesia in palliative care | Great Ormond Street Hospital Google Tag Manager Navigation Search Search You are here Analgesia: use of patient/proxy patient controlled analgesia in palliative care Analgesia: use of patient/proxy patient controlled analgesia in palliative care ; . These techniques are most commonly used following surgery ( ; ), but can also (...) to health care professionals, rather than being trained to take on the responsibility for administration of bolus doses of analgesia. Although this is entirely appropriate in a patient population who are opiate naïve and with limited pain experience, such as the majority of post-operative patients. The palliative care population who will be considered for PCA and PPCA have different characteristics. In this population, patients and parents/carers are experienced in both pain assessment and management

2014 Publication 1593

229. Palliative and End-of-Life Care in Stroke

Palliative and End-of-Life Care in Stroke 1887 Background and Purpose—The purpose of this statement is to delineate basic expectations regarding primary palliative care competencies and skills to be considered, learned, and practiced by providers and healthcare services across hospitals and community settings when caring for patients and families with stroke. Methods—Members of the writing group were appointed by the American Heart Association Stroke Council’s Scientific Statement Oversight (...) Committee and the American Heart Association’s Manuscript Oversight Committee. Members were chosen to reflect the diversity and expertise of professional roles in delivering optimal palliative care. Writing group members were assigned topics relevant to their areas of expertise, reviewed the appropriate literature, and drafted manuscript content and recommendations in accordance with the American Heart Association’s framework for defining classes and level of evidence and recommendations. Results

2014 Congress of Neurological Surgeons

230. Palliative care consultation items

Palliative care consultation items Palliative care consultation items Palliative care consultation items Medical Services Advisory Committee Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Medical Services Advisory Committee. Palliative care consultation items. Canberra: Medical Services Advisory Committee (MSAC). MSAC application 1159. 2014 Authors' conclusions (...) After considering the strength of the available evidence in relation to the safety, clinical effectiveness and cost-effectiveness of palliative care medicine consultation items MSAC considered that there was a lack of evidence to support the claim and that the nature of the application itself was outside MSAC's normal frame for consideration. MSAC, however, noted that there may be some benefit in the introduction of new complex assessment and treatment items for palliative medicine specialists

2014 Health Technology Assessment (HTA) Database.

231. Systematic review and meta-analysis: Home palliative care services increase the chance of adults with advanced illness dying at home and reduce symptom burden without impact on caregiver grief Full Text available with Trip Pro

Systematic review and meta-analysis: Home palliative care services increase the chance of adults with advanced illness dying at home and reduce symptom burden without impact on caregiver grief Home palliative care services increase the chance of adults with advanced illness dying at home and reduce symptom burden without impact on caregiver grief | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings (...) via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Home palliative care services increase

2014 Evidence-Based Nursing

232. Qualitative study: Early ambulatory palliative care visits focus on psychosocial elements such as building rapport and coping, as well as managing symptoms and enhancing illness understanding

Qualitative study: Early ambulatory palliative care visits focus on psychosocial elements such as building rapport and coping, as well as managing symptoms and enhancing illness understanding Early ambulatory palliative care visits focus on psychosocial elements such as building rapport and coping, as well as managing symptoms and enhancing illness understanding | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your (...) care visits focus on psychosocial elements such as building rapport and coping, as well as managing symptoms and enhancing illness understanding Article Text Adult nursing Qualitative study Early ambulatory palliative care visits focus on psychosocial elements such as building rapport and coping, as well as managing symptoms and enhancing illness understanding Betty Ferrell Statistics from Altmetric.com Commentary on: Yoong J , Park ER , Greer JA , et al . Early palliative care in advanced lung

2014 Evidence-Based Nursing

233. Fentanyl transdermal patches in palliative care: clinical effectiveness, safety, and guidelines

Fentanyl transdermal patches in palliative care: clinical effectiveness, safety, and guidelines Fentanyl transdermal patches in palliative care: clinical effectiveness, safety, and guidelines Fentanyl transdermal patches in palliative care: clinical effectiveness, safety, and guidelines CADTH Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database (...) . Citation CADTH. Fentanyl transdermal patches in palliative care: clinical effectiveness, safety, and guidelines. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). Rapid Response. 2014 Authors' conclusions Two evidence-based guidelines regarding the use of fentanyl transdermal patches for pain relief in palliative care patients were identified. Final publication URL Indexing Status Subject indexing assigned by CRD MeSH Administration, Cutaneous; Fentanyls; Palliative Care

2014 Health Technology Assessment (HTA) Database.

234. Early specialty palliative care - translating data in oncology into practice. Full Text available with Trip Pro

Early specialty palliative care - translating data in oncology into practice. 24328469 2013 12 19 2018 11 13 1533-4406 369 24 2013 Dec 12 The New England journal of medicine N. Engl. J. Med. Early specialty palliative care--translating data in oncology into practice. 2347-51 10.1056/NEJMsb1305469 Parikh Ravi B RB From Harvard Medical School (R.B.P.) and Massachusetts General Hospital (J.S.T.) - both in Boston; the American Cancer Society, Washington, DC (R.A.K.); and Johns Hopkins University (...) , Baltimore (T.J.S.). Kirch Rebecca A RA Smith Thomas J TJ Temel Jennifer S JS eng P30 CA006973 CA NCI NIH HHS United States Journal Article United States N Engl J Med 0255562 0028-4793 AIM IM N Engl J Med. 2014 Mar 13;370(11):1074-5 24620887 N Engl J Med. 2014 Mar 13;370(11):1075 24620888 N Engl J Med. 2014 Mar 13;370(11):1075-6 24620886 Cost Savings Health Policy Humans Neoplasms therapy Palliative Care economics legislation & jurisprudence methods Quality of Life Time Factors United States 2013 12 17 6

2013 NEJM

235. The role of healthcare support workers in providing palliative and end-of-life care in the community: a systematic literature review

The role of healthcare support workers in providing palliative and end-of-life care in the community: a systematic literature review The role of healthcare support workers in providing palliative and end-of-life care in the community: a systematic literature review The role of healthcare support workers in providing palliative and end-of-life care in the community: a systematic literature review Herber OR, Johnston BM CRD summary The authors explored the role, challenges and supporting factors (...) by healthcare support workers. Searching CINAHL, EMBASE, PsycINFO, MEDLINE, British Nursing Index, Web of Science and ASSIA were searched for studies published in English in peer-reviewed journals between 1990 and 2011. Search terms were reported. Reference lists were used to locate further studies. The International Journal of Palliative Nursing was handsearched. Study selection Eligible for inclusion were quantitative and qualitative studies that explored the role and associated challenges for health care

2013 DARE.

236. A good death at home: home palliative care services keep people where they want to be

A good death at home: home palliative care services keep people where they want to be A good death at home: home palliative care services keep people where they want to be | Evidently Cochrane sharing the latest Cochrane Reviews Search Main menu Post navigation by Key message: There is good evidence that home palliative care increases the chance of dying at home and reduces symptom burden, especially for people with cancer, without increasing caregiver grief. Where would you prefer to die (...) , if you had an advanced illness? More than 50% of people say they would like to die at home, given the choice, but in many countries relatively few people do; just 21% in England in 2010, for example. The need for home palliative care services is increasing as the ageing population expands and an understanding of their impact on death at home and on things that matter to patients and their carers, such as how well symptoms are controlled and how they feel about their care, is important in working out

2013 Evidently Cochrane

237. Do community specialist palliative care services that provide home nursing increase rates of home death for people with life-limiting illnesses? A systematic review and meta-analysis of comparative studies

Do community specialist palliative care services that provide home nursing increase rates of home death for people with life-limiting illnesses? A systematic review and meta-analysis of comparative studies Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2013 DARE.

238. Levomepromazine for nausea and vomiting in palliative care. (Abstract)

Levomepromazine for nausea and vomiting in palliative care. Nausea and vomiting are common, distressing symptoms for patients receiving palliative care. There are several agents which can be used to treat these symptoms. Levomepromazine is an antipsychotic drug which is commonly used to alleviate nausea and vomiting in palliative care settings.To evaluate the efficacy of and adverse events (both minor and serious) associated with the use of levomepromazine for the treatment of nausea (...) and vomiting in palliative care patients.We searched the electronic databases including CENTRAL, MEDLINE, and EMBASE using relevant search terms and synonyms in March 2013.Randomised controlled trials of levomepromazine for the treatment of nausea or vomiting, or both, for adults receiving palliative care. Studies where symptoms were thought to be due to pregnancy or surgery were excluded.The potential relevance of studies was assessed based on titles and abstracts. Any study reports which appeared to meet

2013 Cochrane

239. Generalist plus Specialist Palliative Care - Creating a More Sustainable Model. Full Text available with Trip Pro

Generalist plus Specialist Palliative Care - Creating a More Sustainable Model. 23465068 2013 04 04 2018 12 02 1533-4406 368 13 2013 Mar 28 The New England journal of medicine N. Engl. J. Med. Generalist plus specialist palliative care--creating a more sustainable model. 1173-5 10.1056/NEJMp1215620 Quill Timothy E TE Department of Medicine, Palliative Care Division, University of Rochester Medical Center, Rochester, NY, USA. Abernethy Amy P AP eng Journal Article 2013 03 06 United States N Engl (...) J Med 0255562 0028-4793 AIM IM J Clin Anesth. 2014 Sep;26(6):429-31 25200705 Curriculum Fellowships and Scholarships Humans Palliative Care standards Specialization Specialty Boards United States Workforce 2013 3 8 6 0 2013 3 8 6 0 2013 4 5 6 0 ppublish 23465068 10.1056/NEJMp1215620

2013 NEJM

240. Methylnaltrexone for treating opioid-induced bowel dysfunction in people with advanced illness receiving palliative care (terminated appraisal) (TA277)

Methylnaltrexone for treating opioid-induced bowel dysfunction in people with advanced illness receiving palliative care (terminated appraisal) (TA277) Overview | Methylnaltrexone for treating opioid-induced bowel dysfunction in people with advanced illness receiving palliative care (terminated appraisal) | Guidance | NICE Methylnaltrexone for treating opioid-induced bowel dysfunction in people with advanced illness receiving palliative care (terminated appraisal) Technology appraisal [TA277 (...) ] Published date: 27 March 2013 Share Guidance NICE is unable to recommend the use in the NHS of methylnaltrexone for treating opioid-induced bowel dysfunction in people with advanced illness receiving palliative care because no evidence submission was received from the manufacturer of the technology. Explore © NICE [year]. All rights reserved. Subject to .

2013 National Institute for Health and Clinical Excellence - Technology Appraisals